Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published May 2017 | public
Book Section - Chapter

Robust control of a powered transfemoral prosthesis device with experimental verification

Abstract

This paper presents, compares, and experimentally implements two robust model-based controllers for transfemoral prosthetic walking: the robust passivity (RP) controller and the robust sliding mode (RS) controller. These findings constitute the first steps toward using model-based controllers for prosthetic devices as an alternative to commonly-used variable impedance and proportional-derivative (PD) control methods. The model upon which the controllers are based is a 5-link planar hybrid system (both continuous and discrete behaviors) with point feet, to represent a transfemoral amputee's body and limbs. A desired walking trajectory is generated through the framework of human-inspired control by solving an optimization problem. Smooth humanlike gait is achieved by combining model information with a desired trajectory. The stability of both controllers is proven for continuous dynamics within the framework of the Lyapunov stability theorem. Simulations show the proposed controllers are capable of meeting specific performance requirements regarding trajectory tracking of the prosthetic knee and convergence to a stable periodic orbit while walking on flat ground. Finally, both RP and RS controllers are experimentally implemented on AMPRO3 (the third iteration of Advanced Mechanical Prosthesis), a custom self-contained powered transfemoral prosthesis. Results show that both controllers provide humanlike walking and accurate tracking performance for a healthy human subject utilizing a transfemoral prosthesis.

Additional Information

© 2017 IEEE. This work is supported by NSF Award NRI-1526519 and NSF Grant 1344954. This research was approved by the George Institute of Technology Institutional Review Board as IRB2014-0382F for testing with humans.

Additional details

Created:
August 19, 2023
Modified:
October 26, 2023